Cargando…
Eupalinilide B as a novel anti-cancer agent that inhibits proliferation and epithelial–mesenchymal transition in laryngeal cancer cells
OBJECTIVE: To investigate the anti-cancer effects and potential mechanisms of eupalinilide B in laryngeal cancer cells. METHODS: Laryngeal cancer cell lines were selected to study the anti-tumor effects of eupalinilide B in vitro and in vivo. Lysine-specific demethylase 1 (LSD1) activity was assesse...
Autores principales: | Jiang, Linlin, Zhang, Lei, Zhang, Xinran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811433/ https://www.ncbi.nlm.nih.gov/pubmed/35098772 http://dx.doi.org/10.1177/03000605211067921 |
Ejemplares similares
-
A novel anti-lung cancer agent inhibits proliferation and
epithelial–mesenchymal transition
por: Zhao, Wen, et al.
Publicado: (2022) -
Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020) -
Effect of KLF17 overexpression on epithelial–mesenchymal transition of gastric cancer cells
por: Li, Shaoyi, et al.
Publicado: (2021) -
Epithelial–mesenchymal transition and metastasis of colon cancer cells induced by the FAK pathway in cancer-associated fibroblasts
por: Xuefeng, Xuefeng, et al.
Publicado: (2020) -
Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway
por: Sun, Yajing, et al.
Publicado: (2021)